Kezar Life Sciences, Inc. (KZR)

7.29 0.00 (0.00%) USD  |  NASDAQ  |  Aug 28, 16:00
More

Kezar Life Sciences Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for KZR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
May 11, 2026 --
March 30, 2026 --
February 20, 2026 --
December 31, 2025 --
November 13, 2025 --
October 17, 2025 --
October 16, 2025 --
September 30, 2025 --
September 24, 2025 --
August 14, 2025 --
July 16, 2025 --
June 30, 2025 --
June 27, 2025 --
May 14, 2025 --
May 13, 2025 --
Date Value
March 25, 2025 --
February 21, 2025 --
December 31, 2024 --
December 02, 2024 --
November 13, 2024 --
September 30, 2024 --
August 14, 2024 --
August 13, 2024 --
May 10, 2024 --
May 09, 2024 --
April 04, 2024 --
March 31, 2024 --
March 25, 2024 --
March 15, 2024 --
February 23, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Brainstorm Cell Therapeutics, Inc. Upgrade
Summit Therapeutics, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade